These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18871883)

  • 1. The reactivity of various human sera with mumps complement fixation antigens.
    HENLE G; HARRIS S; HENLE W
    J Exp Med; 1948 Jul; 88(1):133-47. PubMed ID: 18871883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMMUNITY IN MUMPS : V. THE CORRELATION OF THE PRESENCE OF DERMAL HYPERSENSITIVITY AND RESISTANCE TO MUMPS.
    Enders JF; Kane LW; Maris EP; Stokes J
    J Exp Med; 1946 Sep; 84(4):341-64. PubMed ID: 19871574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The benefit from mumps virus IgG antibody avidity testing in the population with high vaccine coverage in the context of other serological methods for laboratory diagnosis of mumps and the current epidemiological].
    Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Marešová V
    Epidemiol Mikrobiol Imunol; 2016; 65(1):39-44. PubMed ID: 27246643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological studies on 40 cases of mumps virus infection.
    Freeman R; Hambling MH
    J Clin Pathol; 1980 Jan; 33(1):28-32. PubMed ID: 7358857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUMPS MENINGOENCEPHALITIS, TORONTO, 1963.
    MCLEAN DM; BACH RD; LARKE RP; MCNAUGHTON GA
    Can Med Assoc J; 1964 Feb; 90(7):458-62. PubMed ID: 14120950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serological differentiation of mumps complement-fixation antigens.
    HENLE G; HENLE W; HARRIS S
    Proc Soc Exp Biol Med; 1947 Mar; 64(3):290-5. PubMed ID: 20293214
    [No Abstract]   [Full Text] [Related]  

  • 7. IMMUNITY IN MUMPS : IV. THE CORRELATION OF THE PRESENCE OF COMPLEMENT-FIXING ANTIBODY AND RESISTANCE TO MUMPS IN HUMAN BEINGS.
    Maris EP; Enders JF; Stokes J; Kane LW
    J Exp Med; 1946 Sep; 84(4):323-39. PubMed ID: 19871573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMMUNITY IN MUMPS : I. EXPERIMENTS WITH MONKEYS (MACACUS MULATTA). THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY FOLLOWING INFECTION AND EXPERIMENTS ON IMMUNIZATION BY MEANS OF INACTIVATED VIRUS AND CONVALESCENT HUMAN SERUM.
    Enders JF; Kane LW; Cohen S; Levens JH
    J Exp Med; 1945 Jan; 81(1):93-117. PubMed ID: 19871448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the complement fixation antigens in mumps.
    HENLE G; HENLE W; HARRIS S
    J Bacteriol; 1947 Aug; 54(2):278. PubMed ID: 20260795
    [No Abstract]   [Full Text] [Related]  

  • 10. [SERO-EPIDEMIOLOGICAL FINDINGS IN A SAMPLE OF THE POPULATION OF ASMARA (ERITREA). V. INVESTIGATION OF COMPLEMENT-FIXING ANTIBODIES AGAINST MYXOVIRUS PAROTIDITIS].
    TAGLIERI G; TRESCA G
    Arch Ital Sci Med Trop Parassitol; 1964 May; 45():235-42. PubMed ID: 14204512
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contribution of the detection of IgA antibodies to the laboratory diagnosis of mumps in the population with a high vaccination coverage].
    Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Malý M
    Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):16-9. PubMed ID: 25872991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihemagglutinating and neutralizing factors against Newcastle disease virus occurring in sera of Patients convalescent from mumps.
    KILHAM L; JUNGHERR E; LUGINBUHL RE
    J Immunol; 1949 Sep; 63(1):37-49. PubMed ID: 18139407
    [No Abstract]   [Full Text] [Related]  

  • 13. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains.
    Rubin S; Mauldin J; Chumakov K; Vanderzanden J; Iskow R; Carbone K
    Vaccine; 2006 Mar; 24(14):2662-8. PubMed ID: 16309801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of antibodies to viral (V) and soluble (S) antigens of mumps virus in guinea pigs and separation of V and S antibodies by zone electrophoresis.
    OGIWARA H; MATUMOTO M
    Jpn J Exp Med; 1961 Oct; 31():381-93. PubMed ID: 14481301
    [No Abstract]   [Full Text] [Related]  

  • 15. IMMUNITY IN MUMPS : II. THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY AND DERMAL HYPERSENSITIVITY IN HUMAN BEINGS FOLLOWING MUMPS.
    Enders JF; Cohen S; Kane LW
    J Exp Med; 1945 Jan; 81(1):119-35. PubMed ID: 19871439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution to laboratory diagnosis of mumps and parainfluenza.
    Franková V; Holubová J; Grubhoffer L; Kasová V
    Acta Virol; 1988 Nov; 32(6):503-14. PubMed ID: 2906222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute parotitis in children previously vaccinated against mumps].
    Mihály I; Budai J; Gerö A; Kukán E
    Orv Hetil; 1994 Feb; 135(6):287-90. PubMed ID: 8309684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against epidemic parotitis].
    Midulla M; Chiavelli S
    Pediatr Med Chir; 1984; 6(1):25-30. PubMed ID: 6442412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxidase labelled mumps virus antigens and their application in IgM capture immunoassay: first experience.
    Grubhoffer L; Holubová J; Rozprimová L
    Acta Virol; 1987 May; 31(3):249-53. PubMed ID: 2888289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
    Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
    Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.